urothelial cancer

AMBASSADOR Trial: Adjuvant Pembrolizumab in Urothelial Carcinoma

The AMBASSADOR trial is a phase 3 randomized clinical trial aimed at evaluating whether pembrolizumab as adjuvant therapy is more effective than observation in patients with high-risk muscle-invasive urothelial carcinoma after radical surgery. Study Details: Inclusion Criteria: Primary Outcome: Secondary … Read More